Suppr超能文献

乳腺癌相关肝转移的肝切除术:病例报告

Liver resection for breast cancer-related liver metastases: a case report.

作者信息

Pangarsa Eko Adhi, Prabowo Erik, Yudisaputro Wasisto Dwi, Istiadi Hermawan, Hadiyanto Jessica Novia, Tandarto Kevin, Rizky Daniel, Setiawan Budi, Santosa Damai, Suharti Catharina

机构信息

Division of Hematology Medical Oncology, Dr. Kariadi General Hospital Semarang/Faculty of Medicine Diponegoro University, Semarang, Indonesia.

Division of Digestive Surgery, Department of General Surgery, Faculty of Medicine, Diponegoro University/Dr. Kariadi General Hospital Semarang, Semarang, Indonesia.

出版信息

J Med Case Rep. 2024 Dec 23;18(1):635. doi: 10.1186/s13256-024-05001-4.

Abstract

INTRODUCTION

Breast cancer liver metastasis presents a significant challenge in clinical oncology, with limited treatment options and poor prognosis. This case series study explores the extended survival achieved in breast cancer patients with liver metastases through a combination of surgical and medical interventions.

CASE PRESENTATION

We present three cases of Javanese female patients with breast cancer (51 years old, 42 years old, and 55 years old) with liver metastases who underwent hepatic resection followed by systemic therapy. The cases illustrate successful outcomes with disease-free survival ranging from 5 to 31 months post-surgery. Key prognostic factors associated with improved survival include prolonged interval between initial diagnosis and detection of liver metastasis, liver-limited disease, positive response to preoperative systemic therapy, and expression of estrogen and progesterone receptors in the metastatic lesions.

CONCLUSION

These findings underscore the potential efficacy of a multidisciplinary approach integrating local hepatectomy with systemic therapy in selected patients with breast cancer liver metastasis. Further research is warranted to identify optimal patient selection criteria and refine treatment strategies for improved outcomes.

摘要

引言

乳腺癌肝转移在临床肿瘤学中是一项重大挑战,治疗选择有限且预后较差。本病例系列研究探讨了通过手术和药物干预相结合,使乳腺癌肝转移患者获得更长生存期的情况。

病例介绍

我们呈现了三例患有乳腺癌肝转移的爪哇女性患者(分别为51岁、42岁和55岁),她们接受了肝切除手术,随后进行了全身治疗。这些病例显示了成功的结果,术后无病生存期为5至31个月。与生存期改善相关的关键预后因素包括初次诊断与肝转移检测之间的间隔延长、肝局限性疾病、对术前全身治疗的阳性反应以及转移病灶中雌激素和孕激素受体的表达。

结论

这些发现强调了在选定的乳腺癌肝转移患者中,将局部肝切除术与全身治疗相结合的多学科方法的潜在疗效。有必要进行进一步研究,以确定最佳的患者选择标准并完善治疗策略,以改善治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d64/11665236/c0e113a029a4/13256_2024_5001_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验